World Orphan Drug Congress 2026

Exhibiting – Booth #414

ProPharma’s presence as an exhibitor at World Orphan Drug Congress USA 2026 highlights the company’s dedication to supporting organizations across the rare disease and orphan drug development landscape. Taking place June 9–11, 2026, in Boston, Massachusetts, this leading industry event brings together pharmaceutical and biotechnology companies, regulators, patient advocacy groups, investors, and service providers to address the evolving challenges and opportunities within rare disease research, development, and patient access.

The conference agenda covers key topics including clinical development, regulatory strategy, patient engagement, market access, advanced therapies, digital health, and commercialization, creating a valuable platform for industry collaboration and innovation. ProPharma representatives will be available throughout the event to connect with attendees and discuss how our expertise supports organizations advancing therapies for rare disease patients.